Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism

Annals of Medicine

Volumn 42, Issue 3, 2010, Pages 196-206

  Ruchat, Stephanie May ^a,b   Vohl, Marie Claude ^b   Weisnagel, S John ^a,b   Rankinen, Tuomo ^c   Bouchard, Claude ^c   Pérusse, Louis ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Clinical risk factors; Genetic markers; Impaired glucose metabolism; Risk assessment

Indexed keywords

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHI SQUARE TEST; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISORDERS OF CARBOHYDRATE METABOLISM; FAMILY STUDY; FEMALE; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NULL HYPOTHESIS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; ALLELES; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC MARKERS; GENOTYPE; GLUCOSE METABOLISM DISORDERS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 77950795479     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890903559716     Document Type: Article

References (43)

1. International Diabetes Federation. Diabetes Atlas 2007. Available from: www.eatlas.idf.org (accessed 1 February 2007) .
2. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29:1263-1268 (Pubitemid 44125920)
3. Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev. 2000;16:230-236 (Pubitemid 30611783)
4. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359:2072-2077 (Pubitemid 34680970)
5. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. (Pubitemid 34437694)
6. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344: 1343-1350 (Pubitemid 32378388)
7. Schwarz PE, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res. 2009;41:86-97.
8. Freeman H, Cox RD. Type-2 diabetes: A cocktail of genetic discovery. Hum Mol Genet. 2006;15 Spec No 2:R202-9. (Pubitemid 44446795)
9. Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ, Zeggini E, et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 2006;3:e374. (Pubitemid 44721826)
10. Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjogren M, Saloranta C, et al. Genetic prediction of future type 2 diabetes. PLoS Med. 2005;2:e345. (Pubitemid 43020989)
11. Janssens AC, Gwinn M, Khoury MJ, Subramonia-Iyer S. Does genetic testing really improve the prediction of future type 2 diabetes? PLoS Med. 2006;3:e114; author reply e27. (Pubitemid 43362887)
12. Vaxillaire M, Veslot J, Dina C, Proenca C, Cauchi S, Charpentier G, et al. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes. 2008;57:244-254
13. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet. 2007;39: 977-983 (Pubitemid 47185170)
14. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331-1336 (Pubitemid 46871653)
15. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341-1345 (Pubitemid 46871655)
16. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881-885 (Pubitemid 46309843)
17. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678
18. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40:638-645 (Pubitemid 351601209)
19. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316:1336-1341 (Pubitemid 46871654)
20. Lango H, Palmer CN, Morris AD, Zeggini E, Hattersley AT, McCarthy MI, et al. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes. 2008;57:3129-3135
21. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008;359: 2220-2232
22. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008;359:2208-2219
23. Van Hoek M, Dehghan A, Witteman JC, Van Duijn CM, Uitterlinden AG, Oostra BA, et al. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes. 2008;57: 3122-3128
24. Miyake K, Yang W, Hara K, Yasuda K, Horikawa Y, Osawa H, et al. Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J Hum Genet. 2009;54:236-241
25. Bouchard C. Genetic epidemiology, association and sib-pair linkage: results from the Quebec Family Study. In: Bray GA, Ryan DH, editors. Molecular and genetic aspects of obesity. Baton Rouge: Louisiana State University Press; 1996. p. 470-481
26. Perusse L, Rice T, Bouchard C, Vogler GP, Rao DC. Cardiovascular risk factors in a French-Canadian population: resolution of genetic and familial environmental effects on blood pressure by using extensive information on environmental correlates. Am J Hum Genet. 1989;45: 240-251 (Pubitemid 19218231)
27. Rice T, Nadeau A, Perusse L, Bouchard C, Rao DC. Familial correlations in the Quebec family study: cross-trait familial resemblance for body fat with plasma glucose and insulin. Diabetologia. 1996;39:1357-1364 (Pubitemid 26356067)
28. World Health Organization. Definition, diagnosis and classifi cation of diabetes mellitus and its complications. Geneva: World Health Organization; 1999.
29. Chagnon YC, Borecki IB, Perusse L, Roy S, Lacaille M, Chagnon M, et al. Genome-wide search for genes related to the fat-free body mass in the Quebec family study. Metabolism. 2000;49:203-207 (Pubitemid 30090884)
30. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal. 1999;14:143-149
31. O'Connell JR, Weeks DE. PedCheck: a program for identifi cation of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998;63:259-266
32. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 1995;29: 311-322
33. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845
34. Hertel JK, Johansson S, Raeder H, Midthjell K, Lyssenko V, Groop L, et al. Genetic analysis of recently identifi ed type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia. 2008;51:971-977
35. Horikawa Y, Miyake K, Yasuda K, Enya M, Hirota Y, Yamagata K, et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab. 2008;93:3136-3141
36. Lee YH, Kang ES, Kim SH, Han SJ, Kim CH, Kim HJ, et al. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet. 2008;53:991-998
37. Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes. 2008;57:791-795
38. Tabara Y, Osawa H, Kawamoto R, Onuma H, Shimizu I, Miki T, et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes. 2009;58:493-498
39. Cauchi S, Meyre D, Durand E, Proenca C, Marre M, Hadjadj S, et al. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One. 2008; 3:e2031
40. Janssens AC, Pardo MC, Steyerberg EW, Van Duijn CM. Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am J Hum Genet. 2004;74:585-588
41. Janssens AC, Aulchenko YS, Elefante S, Borsboom GJ, Steyerberg EW, Van Duijn CM. Predictive testing for complex diseases using multiple genes: fact or fi ction? Genet Med. 2006;8:395-400.
42. Yang Q, Khoury MJ, Friedman J, Little J, Flanders WD. How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol. 2005;34:1129-1137
43. Lu Q, Elston RC. Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes. Am J Hum Genet. 2008;82: 641-651